Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020

SELL
$270.93 - $320.3 $146,031 - $172,641
-539 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$243.44 - $359.98 $131,214 - $194,029
539 New
539 $149,000
Q3 2019

Nov 08, 2019

SELL
$294.25 - $341.49 $190,674 - $221,285
-648 Closed
0 $0
Q2 2019

Jul 29, 2019

SELL
$279.29 - $336.89 $14,802 - $17,855
-53 Reduced 7.56%
648 $219,000
Q1 2019

May 13, 2019

SELL
$246.18 - $297.25 $33,234 - $40,128
-135 Reduced 16.15%
701 $208,000
Q4 2018

Feb 12, 2019

SELL
$232.7 - $281.66 $29,552 - $35,770
-127 Reduced 13.19%
836 $213,000
Q3 2018

Nov 09, 2018

BUY
$236.3 - $277.15 $13,941 - $16,351
59 Added 6.53%
963 $267,000
Q2 2018

Aug 14, 2018

BUY
$217.98 - $237.23 $197,053 - $214,455
904 New
904 $213,000

Others Institutions Holding COO

About COOPER COMPANIES, INC.


  • Ticker COO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 49,346,000
  • Market Cap $4.62B
  • Description
  • The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...
More about COO
Track This Portfolio

Track Claraphi Advisory Network, LLC Portfolio

Follow Claraphi Advisory Network, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Claraphi Advisory Network, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Claraphi Advisory Network, LLC with notifications on news.